|
Search
Collections
Benchmarks
Upload document
Organization
Kaiser Permanente San Diego
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Outcomes of reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer.
Org:
Kaiser Permanente San Diego,
Kaiser Permanente National Drug Use Management,
